Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Michigan Plans to Ease Access to the Recreational Cannabis Market Next Year

In an effort to curb black-market sales, Michigan is planning to ease access to the recreational cannabis market next year. In March, Michigan will remove a prerequisite that was included with good intentions but has unintentionally complicated the fight against unlicensed, black market cannabis, the state Marijuana Regulatory Agency announced. From March next year, certain licensed recreational marijuana businesses will no longer be required to first hold a medical license.

Retailers, processors, transporters, safety labs, class B, and class C growers will be subject to lower license fees should they wish to grow, sell, test, or transport recreational marijuana. Most importantly, new businesses that aren’t interested in medical cannabis will now be able to access the recreational cannabis market. The prerequisite was a major barrier to entry into the recreational cannabis sector. Although Michigan issued the first medical licenses in 2018, recreational cannabis dispensaries didn’t start opening until last December.

The original intent of the medical license prerequisite was to give pioneering companies that assumed risk and invested early a chance to establish themselves and recoup costs before the recreational market with its competition could be opened to other players, explains Robin Schneider director of the Michigan Cannabis Industry Association, a trade organization comprised of over 200 marijuana businesses.

Although the prerequisite was to remain in place for two years after the state began awarding licenses last November, there was one caveat. The recreational cannabis law passed in 2018 by voters stated that the state could do away with the requirement one year after the first recreational business applications were received either to curb black-market sales, increase access to rural communities, or to satisfy supply shortages.

In this case, difficulty combating unlicensed and untested marijuana necessitated the move, the Marijuana Regulatory Agency says. “According to data provided by the Michigan State Police Marijuana and Tobacco Investigation Section, 80% of the seizures of illicit marijuana occur in municipalities that do not have regulated marijuana establishments. In the past year, the city of Detroit has seen a 365% increase in narcotics-related homicides and a 214% increase specifically in marijuana-related non-fatal shootings,” the agency says.

“As municipalities throughout the state consider ordinances to allow marijuana establishments, the current eligibility restriction acts as a barrier to approaching local authorization in a way that is equitable. Greater municipal participation is a critical element in reducing the impact of the illicit market.” Additionally, Marijuana Regulatory Agency Director Andrew Brisho says, short supply in the nascent cannabis market has also been an issue.

“We certainly aren’t meeting demand yet, but I think it is important to consider the pace of growth in the regulated market, and whether that is consistently increasing to meet that demand at some point in a reasonable time frame.”

It would be interesting to hear what companies like Pure Extract Technologies Inc. think of how effective the plans of the Michigan authorities are likely to be.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Top Arguments for Legalizing Marijuana Sales and Consumption

For the past couple of years, attitudes towards cannabis have been on the mend. Although the controversial plant is still considered illegal at the federal level, over 30 states have legalized it to varying degrees. Renowned for a long time due to its psychoactive abilities, cannabis is increasingly being considered medicinal, with plenty of people using it to help manage conditions like chronic pain in lieu of pharmaceuticals.

We are still a long way from federal decriminalization, though. Cannabis reform activists have been working hard to convince the masses of the benefits of legalizing cannabis. The following are some of the arguments activists have used in favor of cannabis legalization and regulation;

Cannabis is a medicine. Although the hype around cannabis’ medicinal properties has outpaced the science, the plant has still been proven to be an effective treatment in some cases. Research has found that cannabis can help reduce nausea and vomiting in cancer patients undergoing chemotherapy as well as intractable seizures caused by pediatric epilepsy. Additionally, cannabis is effective against chronic, pain, stress, anxiety, and a host of other medical conditions.

Cannabis arrests are a waste of resources. The police make more than 660,000 cannabis arrests each year, more than for any other drug. These arrests are mostly for possession, inflicting tens of billions of dollars in economic damage annually, with police dedicating $3.6bn annually to enforce possession laws. If you’re arrested for marijuana possession, it can cost you anywhere from $2,000 to $20,000 to defend yourself in court, not to mention the fines you may have to pay if you lose. All this resource hemorrhage is avoidable.

Most people arrested for cannabis possession are harmless. Most people who use cannabis recreationally and even medically don’t fit into the stereotypical ‘criminal’ role. At best, they just want to smoke (or eat) their marijuana, maybe watch a movie, relax, and go to sleep. However, 92% of marijuana arrests are for possession, branding decent, law-abiding citizens as criminals. And once a drug arrest or even incarceration is on your permanent record, you’ll have a lot of trouble finding adequate employment or even good housing in the future.

Legalization will boost the economy, especially in the coming years as the country struggles to recover from the economic crisis caused by the coronavirus pandemic. The state-legal cannabis industry is already worth $10.73 billion and has created over 200,000 jobs in the U.S. Additionally, states that have legalized cannabis have consistently brought in millions of dollars in cannabis tax. California, for instance, collected a whopping $305 million in cannabis excise tax revenue alone and $635 million total in state and local revenue in its second year of legal sales.

As we head into the next year, legalizing cannabis can help boost the economy by filling state coffers with cannabis tax and providing gainful employment to people who need it. Entities like Pac Roots Cannabis Corp. (CSE: PACR) know all too well the economic potential of marijuana, and that is probably why the industry is so vocal in urging the authorities to create regulated markets for these products.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Illinois Marijuana Sales Still Surging, Data Shows

Months into the coronavirus pandemic, the state-legal cannabis industry is still going strong. Although the pandemic forced many industries to shut down, resulting in the loss of millions of jobs, the cannabis industry has fared quite well despite the economic crisis. Most states have seen increased cannabis sales month over month, with some even calling the industry ‘recession-proof’.

One such state is Illinois, which has seen record-breaking marijuana sales for the fifth time in a row. In September, consumers purchased more than 1.4 million marijuana products worth nearly $67 million, with almost $18 million of those sales coming from out-of-state visitors, according to the state Department of Financial and Professional Regulation. This is a slight increase compared to the 1.3 million marijuana products sold for a total of nearly $64 million in August.

In July, Illinois reported nearly $61 million in adult-use cannabis sales, beating out by a wide margin the $44,749,787 worth of cannabis sold in June.

Although the data from September doesn’t include data about purchases made through the state’s medical cannabis program, it seems to support the notion that the cannabis industry is recession-proof.

Like most states that have legalized cannabis, Illinois declared the cannabis industry essential, allowing businesses to keep operating amidst the lockdown orders.

State officials say that although the month over month increase in sales is positive economic news, they are more interested in directing cannabis tax revenue towards restorative justice measures. Most states that allow cannabis have provisions that allocate cannabis tax revenue to programs that reinvest in communities most affected by the decades’ long war on drugs and Illinois is no different.

Illinois has brought in around $52 million in cannabis tax revenue in the first six months since retail sales began in January. Back in May, the state announced that $31 million in restorative justice grants sourced from cannabis sales tax would be available. Under a Restore, Reinvest, and Renew (R3) program established by the legalization bill, the funds would be used to provide grant opportunities for “communities impacted by economic disinvestment, violence and the severe and multilayered harm caused by the war on drugs.”

Later in July, the state announced that 25% of cannabis tax revenue would go toward a social equity program. “We were not doing this to make as much money as we could, “says Toi Hutchinsons, senior cannabis advisor to Gov. J.B Pritzker. “We were actually doing this for the people.”

Many cannabis industry players like The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) believe that legalizing and regulating the industry would bring untold economic benefits, and the figures from Illinois prove this to be the case.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Updates Shareholders on Two Key Initiatives

Sugarmade (OTCQB: SGMD), today issued a letter to its shareholders, on behalf of its CEO Jimmy Chan, that provided an update on coming expansion steps in regard to its BudCars delivery service as well as the company’s vertical integration. “Today, I want to highlight two themes that will help to drive our value proposition for shareholders over the intermediate term: geographic expansion for BudCars and our move to vertically integrate through the establishment of cultivation operations. Together, they represent tangible catalysts driving both top and bottom-line growth,” Chan stated in the update. “These are exciting times for Sugarmade. We have a rapidly growing business, and we are taking concrete steps now to build on that growth. Once again, we are very grateful to our committed base of support, and I look forward to keeping you engaged as we continue to make new strides and reach new milestones.”

To view the full press release, visit https://cnw.fm/z3PYG

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. For more information, visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Mark Zuckerberg Makes Donation in Support of Oregon Drug Decriminalization Campaign

A foundation run by Facebook founder and CEO Mark Zuckerberg and his wife Priscilla Chan has made a donation in support of a ballot measure to decriminalize all drugs in Oregon. The Chan Zuckerberg Initiative Advocacy donated $500,000 in support of Measure 110, a ballot measure “designed to establish a more humane and effective approach to drugs.” On top of that, the measure would use a portion of existing legal marijuana tax revenue to pay for expanded substance misuse treatment services, establishing addiction recovery centers throughout the state.

According to supporters of Measure 110, it is part of an effort to stop seeing drug misuse and addiction as a public health issue rather than a criminal issue. Also called the Drug Addiction Treatment and Recovery Act, the measure has been endorsed by more than 50 organizations including ACLU Oregon, United Seniors of Oregon, Oregon Latino Health Coalition, Oregon State Council For Retired Citizens, the Confederated Tribes of the Brande Ronde, Human Rights Watch and Drug Policy Action. It has also been backed by two currently serving district attorneys as well as two former U.S. attorneys.

If the measure is approved, low-level possession would be considered a civil infraction punishable by a maximum of $100 fine and no jail time. The $500,000 contribution from Chan Zuckerberg Initiative Advocacy is the second-largest donation, after the $850,000 donated by the Drug Policy Alliance’s political arm Drug Policy Action. ACLU Oregon also made a donation of $100,000.

The campaign has also received more than 400 individual donations. The median donation amount is around $50, with more than 83% of the contributions being made by Oregonians. “People with addiction need help, not punishment, and we are excited so many people are stepping forward to help win a more humane, equitable, and effective approach to drug addiction in Oregon,” says Peter Zuckerman, Yes on Measure 110’s campaign manager.

In the fiscal year 2018, there were 8,903 simple drug possession arrests, averaging at more than one arrest every hour, according to the Oregon Criminal Justice Commission. “Oregon law enforcement needs to stop making these kinds of arrests, targeting our communities and ruining our lives by giving us criminal records,” says Kayse Jama, executive director of Unite Oregon, which endorsed the measure.

“The need for this measure is more urgent right now more than ever because jails and prisons have turned into contagion hotspots during the pandemic.”

The support that the campaign in Oregon is receiving is likely to be putting a smile on the faces of cannabis companies like Sugarmade, Inc. (OTCQB: SGMD).

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Highest Court in Florida to Revisit Law Establishing Medical Cannabis Program

Although medical cannabis has been legalized in over 30 states for quite a while now, the industry still has plenty of growing pains. Aside from being denied access to banking services, players in the industry across the country have been at loggerheads with authorities over how licenses are awarded. In Florida, for instance, medical cannabis law requires that licensed companies must be able to handle all aspects of the business, including growing, processing, and distributing products.

Referred to as ‘vertical integration,’ the system locks out a large number of cannabis businesses and limits the licenses only to companies that can handle all aspects of the business from cultivation all the way to sales, says cannabis businesses. In 2018, Tampa-based cannabis company Florigrown sued the state, challenging the state law, passed in 2017 requiring licensed cannabis businesses to have a vertically integrated structure.

In May this year, Justices at the Florida Supreme Court heard arguments challenging the constitutionality of the state law that determines licensee’s eligibility. Later in July, the Supreme Court scheduled another round of arguments on whether the 2017 law is an unconstitutional “special’ law, with the arguments set for this week. ‘Special laws’ are policies that are generally intended to benefit specific entities and they are barred by the Florida Constitution.

According to the Florigrown lawsuit, parts of the 2017 law improperly limited firms that could take part in the nascent medical cannabis industry. “This Supreme Court has already held that the controlling question in evaluating whether a law is an unconstitutional special law is closed. Here, the classes are so clearly closed, the legislature might as well have named the licensees in the statute,” Florigrown lawyers wrote in a brief.

However, lawyers for the Florida Department of Health, which oversees the state’s medical cannabis industry responded in a brief that the 2017 law “ultimately establishes a comprehensive and unified statutory system for the statewide licensure and regulation of medical marijuana firms,” otherwise known as medical marijuana treatment centers (MMTCs). “The statute did not create a closed universe of licensed MMTCs. The MMTC licensure statute, viewed properly as a comprehensive and unified whole, does not provide a benefit to private corporations that others, like Florigrown, do not or cannot also receive,” the state brief said.

Florigrown, on the other hand, argues that that was not the intention of the constitutional amendment allowing medical marijuana sales. The firm contends that a vertical integration system limits the number of companies that can take part in the industry, with a better alternative being a “horizontal” structure where different firms could perform different aspects of the business.

Analysts say sector players like Pure Extract Technologies Inc. will be following this case closely as other jurisdictions could take cues from the outcome in Florida.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Expansion in the US

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before the U.S. election, where six states will vote on cannabis legalization initiatives and the potential power shift at the federal level could lead to more progressive policies for the industry. Among the highlights, Canopy Rivers announced the following: TerrAscend Corp. commenced sales from its newly expanded State Flower cultivation facility in San Francisco; High Beauty Inc. introduced canBE, a new line of natural, aloe-based products combining hemp seed oil, organic plant oils, essential vitamins, antioxidants, and bioflavonoids; and Headset Inc. launched its competitive intelligence tool, Headset Insights Pulse, in Massachusetts.

To view the full press release, visit https://cnw.fm/pgfhq

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging industry insights, in-house expertise and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders exposure to specialized and disruptive cannabis companies. Canopy Rivers’ mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, the company is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Tilray, Inc. (NASDAQ: TLRY) Announces Positive Research Results for Cancer Sufferers

Medical cannabis is probably one of the most controversial topics at the moment. Critics of the medical marijuana movement have claimed that there is hardly any evidence of therapeutic benefit and that the hype has far outpaced the science. On the other hand, cannabis reform activists have argued that due to its diverse medicinal properties, medical cannabis can be a great alternative to pharmaceuticals.

Quite recently, Tilray (NASDAQ: TLRY) announced that Australian researchers have found that medical cannabis has shown promise as a treatment for nausea and vomiting for cancer patients undergoing chemotherapy in a clinical trial. The trial’s preliminary findings, which showed a significant improvement in the control of chemotherapy-induced nausea and vomiting, were published in the Annals of Oncology. The pilot phase of the study consisted of 81 patients who had experienced nausea and vomiting during chemotherapy and it ran for two and a half years.

A quarter of the participants taking medical cannabis experienced no vomiting or nausea compared to 14 percent of people who took a placebo. “The side-effects associated with chemotherapy are some of the primary causes of treatment discontinuation,” says Philippe Lucas, Vice President of Global Research and Access at Tilray, “so improving the control of nausea and vomiting can not only improve the quality of life of patients, but by allowing those affected by cancer to complete their treatment it can also potentially save lives.”

At the moment, the most prescribed medicine for chemo-induced nausea is the synthetic drug Marinol, owned by biotech company AbbVie. However, plenty of patients have been unable to continue with it due to side effects such as mood changes, confusion, trouble concentrating, dizziness, and anxiety. “Nausea and vomiting are among the most distressing and feared consequences of chemotherapy,” says Peter Grimson, leader of the study, medical oncologist at Chris O’Brien Lifehouse and Associate Professor at the University of Sidney.

Although side effects such as sedation, drowsiness, and dizziness were present in moderate to severe levels in about one-third of the people using medical cannabis, researchers considered them manageable. “These encouraging results indicate medical cannabis can help improve quality of life for chemotherapy patients,” Grimson says.

“The trial will now move to a larger phase to determine with much more certainty how effective medicinal cannabis is and whether it should be considered for use in routine cancer care. The next phase of the trial is ongoing and will recruit an extra 170 people.” Grimson added.

Experts say this research goes a long way towards confirming what pot companies like Pac Roots Cannabis Corp. (CSE: PACR) have always said about the myriad of benefits of marijuana.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Congress Again Includes Cannabis Banking Protections in Third Stimulus Bill

Players in the cannabis space are cautiously optimistic after the House of Representatives approved a wide-ranging coronavirus relief bill containing text from the Secure and Fair Enforcement (“SAFE”) Banking Act. For the longest time, players in the cannabis space have been unable to access banking services due to cannabis’ status as a Schedule I drug, forcing them to rely on cash-only transactions. Not only does this put them at risk of theft and burglary, but it also makes social distancing during the pandemic almost impossible.

Passed by the House last year but held in limbo in Senate, the SAFE Banking Act would protect banking institutions and allow them to serve cannabis businesses without fear of federal reprisal.

This is the second time this year that the House has inserted cannabis banking language in a Coronavirus relief bill. But while cannabis banking is an issue that’s dear to the Democrats, the Republican-controlled Senate has been in staunch opposition to the inclusion of cannabis banking in a coronavirus relief bill. Both Senate Majority Leader Mitch McConnell and Vice President Mike Pence have criticized the marijuana components, arguing that they don’t relate to the matter at hand.

Just a day before Thursday’s vote, McConnell took to the floor of his own chamber to say that the House Bill provides “special treatment to the marijuana industry,” adding that the legislation mentions the word ‘cannabis’ more times than the words ‘job’ or ‘jobs.’ And unlike the House, the Republican-held senate did not include cannabis banking language in its own version of the coronavirus relief bill filed back in July.

However, Democratic leaders, as well as cannabis reform advocates, argue that granting cannabis businesses access to banking institutions could reduce the spread of the coronavirus by reducing the industry’s reliance on cash-only transactions. On top of that, allowing small cannabis businesses to bank with financial institutions gives them access to much-needed capital.

“The continued inclusion of my SAFE Banking Act in this package is important for the cannabis industry and its workers,” says Rep. Ed Perlmutter, the lead sponsor of the cannabis banking legislation. “The industry faces an increased public safety risk and public health risk by being forced to make transactions in all cash. The SAFE Banking Act, which already passed the House with a broad bipartisan vote, will take cash off the streets, enable better social distancing in transactions, and support good-paying jobs in communities across the country when we need them most.”

It remains to be seen whether the hopes of cannabis companies like The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) will be fulfilled or put on ice yet again.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Board Appointment of Seasoned Retail Veteran

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced the appointment of retail industry veteran Frank Lazaran to its board of directors, effective Oct. 8, 2020. Lazaran will serve on the company’s audit and compensation committees. Simultaneous to the appointment, Bruce Leitch has decided to step down from the company’s board of directors to focus on other business endeavors. “On behalf of the board, we are delighted to welcome Frank Lazaran as a full-time member of The Alkaline Water Company’s Board of Directors,” WTER Chairman of the Board Aaron Keay said in the news release. “Frank is a seasoned industry veteran with experience and knowledge that will be instrumental as we scale our growing lifestyle brands to existing and new trade channels. Also, we want to thank Bruce for his outstanding leadership and guidance since 2016. His various contributions have helped to drive growth and innovation for our core brand, Alkaline88(R), and our emerging portfolio of A88 Infused(TM) and A88CBD(TM) products.”

To view the full press release, visit https://cnw.fm/8o7ab

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com